Neurology Updates

Neurology Updates

Here you will find regular scientific news from our Scientific Panels. We cover all areas of neurology, including rare diseases. The most recent news are displayed below. You will find all news of different areas sorted into the subsections of the respective scientific panel. Enjoy reading!

Process for SP Submissions

If you want to submit a neurology update for your scientific panel, please find related information here:

| Muscle & Neuromuscular Junction Disorders | Rare Neurological Diseases  

Rozanolixizumab is subcutaneous infused monoclonal antibody targeting the neonatal Fc receptor (FcRn) in adult with MG.

As already presented…

more...
| Muscle & Neuromuscular Junction Disorders | Rare Neurological Diseases  

An interim analysis of the phase 3 open-label extension study (RAISE-XT) testing zilucoplan (a self-administered subcutaneous complement C5 inhibitor)…

more...
| Muscle & Neuromuscular Junction Disorders | Rare Neurological Diseases  

Eculizumab (Soliris; Alexion) is an intravenous complement C5 inhibitor originally approved by FDA and EMA in adult’s patient with anti-acetylcholine…

more...
| COVID-19 | Muscle & Neuromuscular Junction Disorders  

Neuromuscular diseases are a group of heterogenic rare conditions, that can be due to a genetic cause, inflammatory processes or dysimmune disorders.…

more...
| Muscle & Neuromuscular Junction Disorders  

An integrated approach, merging accurate genetic and clinical data, is critical to properly study the effect of new treatments in FSHD.

more...
| Muscle & Neuromuscular Junction Disorders | Rare Neurological Diseases  

Dear colleagues, 

we would like to drive your attention to the recent developments in Spinal Muscular Atrophy. Two different approaches (use of…

more...
| Muscle & Neuromuscular Junction Disorders  

The use of statins in neurocardiovascular conditions has widely increased over the decades. Based on extension of indications major side effects of…

more...